Altreconomia, an Italian magazine, has published on-line the “secret agreement” between the Italian government and the pharmaceutical company Novartis to buy 24 million doses of the swine flu vaccine. The article said that the agreement was too partial to Novartis, because the company was liable only for damages caused by defects of production, it was made no responsible for any delay in the production, and also because the vaccines were too expensive (168 million euro + VAT). These were the objections made by the article, that were reported by many other media. There's a feeling in Italy that the vaccination campaign has been a big business for the pharmaceuthical companies, not accetable given the mildness of the pandemic. The objections were first risen by a decision of Corte dei Conti, the court of law that checks that the financial government's acts are in accordance with the rules. The Corte dei Conti concluded that the government had to accept such unfavourable provisions because of the urgency of the matter. Actually, the timing of the production and delivery of the vaccines has been one of the troubles, but on this issue there's no debating.
20 Jan 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment